Skip to Main Content

Author Details

Inna Y Gong
University of Toronto
2010
44
17
PMIDPaper TitleJournal TitlePublished Year
36321960Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer.J Natl Cancer Inst2023
37548344Comparative effectiveness of salvage chemotherapy regimens and chimeric antigen T-cell receptor therapies in relapsed and refractory diffuse large B cell lymphoma: a network meta-analysis of clinical trials.Leuk Lymphoma2023
37531271Mortality among patients with diffuse large B-cell lymphoma and mental disorders: a population-based study.J Natl Cancer Inst2023
37422530Fracture risk among patients with cancer compared to individuals without cancer: a population-based study.Br J Cancer2023
36580318Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer.JAMA Oncol2023
35007350COVID-19 vaccine response in patients with hematologic malignancy: A systematic review and meta-analysis.Am J Hematol2022
33022231Levothyroxine dose and risk of atrial fibrillation: A nested case-control study.Am Heart J2021
33646496Left atrial volume and function measured by cardiac magnetic resonance imaging as predictors of shocks and mortality in patients with implantable cardioverter-defibrillators.Int J Cardiovasc Imaging2021
33993383Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors.Cancer Chemother Pharmacol2021
34152403Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients.Blood Adv2021
34339289Clinical Outcomes Following Regionalization of Gastric Cancer Care in a US Integrated Health Care System.J Clin Oncol2021
33409570Association between diabetes and haematological malignancies: a population-based study.Diabetologia2021
32236828Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes.Breast Cancer Res Treat2020
31787435Sex-Specific Differences in New York Heart Association Classification and Outcomes of Decompensated Heart Failure.Can J Cardiol2020
33113551Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients.Blood2020
32386773Reply to Sepehrvand et al.-Promoting Enrollment of Women in Cardiovascular Clinical Trials.Can J Cardiol2020
30506689Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals.Clin Pharmacol Ther2019
31030866Temporal Trends of Women Enrollment in Major Cardiovascular Randomized Clinical Trials.Can J Cardiol2019
30815847Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations.Clin Pharmacokinet2019
30390170Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study.Int J Cardiovasc Imaging2019
29211307Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013.Cancer2018
30216362Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.PLoS One2018
30128950A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors.Cancer Chemother Pharmacol2018
29579611A new risk stratification tool for women with acute coronary syndrome.Int J Cardiol2018
28645803GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.Int J Cardiol2017
28449783Effect of Ticagrelor Versus Clopidogrel on Vascular Reactivity.J Am Coll Cardiol2017
26951081Tumour infiltrating lymphocytes and stromal CD68 in early stage HER2 positive breast cancer.J Clin Pathol2016
27271767Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study.Breast Cancer Res Treat2016
25091263Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results.Int J Clin Oncol2015
26100816Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial Findings.Ann Surg Oncol2015
25739672Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.Clin Cancer Res2015
25519011Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesothelioma.Cancer Biomark2015
24423918S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma.Br J Cancer2014
23047721Impact of genetic variation in OATP transporters to drug disposition and response.Drug Metab Pharmacokinet2013
23605084Determination of clinically therapeutic endoxifen concentrations based on efficacy from human MCF7 breast cancer xenografts.Breast Cancer Res Treat2013
23790595Importance of pharmacokinetic profile and variability as determinants of dose and response to dabigatran, rivaroxaban, and apixaban.Can J Cardiol2013
23580071CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy.Breast Cancer Res Treat2013
22958812Absence of both MDR1 (ABCB1) and breast cancer resistance protein (ABCG2) transporters significantly alters rivaroxaban disposition and central nervous system entry.Basic Clin Pharmacol Toxicol2013
22374717Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response.Eur Heart J2012
21725053Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy.Blood2011
22043324Low-lying rectal cancer with anal canal involvement: abdominoperineal or low anterior resection after neoadjuvant chemoradiotherapy.Gastrointest Cancer Res2011
22114699Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation.PLoS One2011
21803659Cytochrome P450 2D6 phenotyping in an elderly population with dementia and response to galantamine in dementia: a pilot study.Am J Geriatr Pharmacother2011
20837591Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions.Pediatrics2010
  • 1 - 44 of 44

Recommended Authors

Clara Oromendia
Weill Cornell Medical College
Career Start Year 2017
Number of shared co-authors 0
Jessica A Lavery
Memorial Sloan Kettering Cancer Center
Career Start Year 2015
Number of shared co-authors 1
Tristan Grogan
University of California Los Angeles
Career Start Year 2013
Number of shared co-authors 1
Martin Goros
University of Texas Health San Antonio
Career Start Year 2013
Number of shared co-authors 0
Seyed Hamidreza Mahmoudpour
Institute for Medical Biostatistics, University Medical Center Mainz
Career Start Year 2013
Number of shared co-authors 3
Matthew A Hathcock
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 1
Jacob P VanHouten
Griffin Hospital
Career Start Year 2012
Number of shared co-authors 2
Irbaz Bin Riaz
Mayo Clinic
Career Start Year 2012
Number of shared co-authors 0
Kelley M Kidwell
University of Michigan School of Public Health ann arbor
Career Start Year 2009
Number of shared co-authors 0
Rafia Bhore
Regeneron Pharmaceuticals
Career Start Year 2009
Number of shared co-authors 0
Daniela Markovic
David Geffen School of Medicine at university of california los angeles
Career Start Year 2009
Number of shared co-authors 0
Raluca Ionescu-Ittu
Analysis Group Inc.
Career Start Year 2007
Number of shared co-authors 0
Fang-Shu Ou
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 0
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Matthieu Resche-Rigon
Universite Paris-Cite, INSERM
Career Start Year 2006
Number of shared co-authors 0
Rickey E Carter
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 0
Jessica K Paulus
Hospital of the University of Pennsylvania
Career Start Year 2003
Number of shared co-authors 0
Keyue Ding
Queen's University
Career Start Year 2002
Number of shared co-authors 2
Lu Tian
Stanford University
Career Start Year 2001
Number of shared co-authors 0
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 3
Ronghui Xu
University of California San Diego
Career Start Year 2000
Number of shared co-authors 1
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 2
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 0
Manisha Desai
Stanford University
Career Start Year 1997
Number of shared co-authors 0
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 1
Madhu Mazumdar
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 1
Terry M Therneau
Mayo Clinic
Career Start Year 1986
Number of shared co-authors 0
Donald A Berry
MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 0
Judith D Goldberg
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Craig C Earle
Odette Cancer Centre
Co-authored papers 3
Larisa H Cavallari
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 2
Primo N Lara
University of California Davis Comprehensive Cancer Center
Co-authored papers 2
Charles M Stein
Vanderbilt University School of Medicine
Co-authored papers 2
Dan M Roden
Vanderbilt University Medical Center
Co-authored papers 2
Andrea H Ramirez
Vanderbilt University Medical Center
Co-authored papers 1
Laurel A Beckett
University of California davis
Co-authored papers 1
Panos Deloukas
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 1
Richard L Berg
Marshfield Clinic Research Institute
Co-authored papers 1
Michael R Hayden
Co-authored papers 1
Bruce C Carleton
BC Children's Hospital Research Institute
Co-authored papers 1
Natalie S Fox
University of California los angeles
Co-authored papers 1
Anthonius de Boer
Co-authored papers 1
George Tomlinson
University Health Network
Co-authored papers 1
Joshua C Denny
Vanderbilt University
Co-authored papers 1
Julie A Johnson
Department of Pharmacotherapy and Translational Research, University of Florida
Co-authored papers 1
Yusuke Nakamura
Japanese Foundation for Cancer Research
Co-authored papers 1
Steven A Lubitz
Cardiovascular Research Center, Massachusetts General Hospital
Co-authored papers 1
Taimour Y Langaee
Center for Pharmacogenomics and Precision Medicine, University of Florida
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Anke H Maitland-van der Zee
Amsterdam UMC location University of Amsterdam
Co-authored papers 1
Guilherme Suarez-Kurtz
Instituto Nacional de Cancer
Co-authored papers 1
Nita A Limdi
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 1
Stuart A Scott
Stanford University
Co-authored papers 1
Muhammad Mamdani
Institute of Health Policy, University of Toronto
Co-authored papers 1
Vincent Huang
Ontario Institute for Cancer Research
Co-authored papers 1
Keith A A Fox
Co-authored papers 1
Russ B Altman
Stanford University
Co-authored papers 1
Release 1.2